231 related articles for article (PubMed ID: 20651842)
1. Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells.
Qi Z; Xu X; Zhang B; Li Y; Liu J; Chen S; Chen G; Huo X
Biochem Cell Biol; 2010 Aug; 88(4):697-704. PubMed ID: 20651842
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
5. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
Gu W; Payne E; Sun S; Burgess M; McMillan NA
Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
[TBL] [Abstract][Full Text] [Related]
7. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
[TBL] [Abstract][Full Text] [Related]
8. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
9. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
[TBL] [Abstract][Full Text] [Related]
11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
12. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
[TBL] [Abstract][Full Text] [Related]
13. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
14. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
[TBL] [Abstract][Full Text] [Related]
15. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
[TBL] [Abstract][Full Text] [Related]
16. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
17. [Inhibiting effect of HPV16 E6 small interfering RNA on the growth of human cervical carcinoma xenotransplanted in nude mice].
Guan LL; Peng ZL; Niu XY
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):894-7. PubMed ID: 18478926
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
[TBL] [Abstract][Full Text] [Related]
19. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy.
Wang W; Xia X; Wang S; Sima N; Li Y; Han Z; Gao Q; Luo A; Li K; Meng L; Zhou J; Wang C; Shen K; Ma D
Cancer Gene Ther; 2011 Nov; 18(11):825-36. PubMed ID: 21852812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
